ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,809Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 823

$515K Total Retail Price of All Prescriptions

Rank: 89 out of 823

550 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 550 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 6,609 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LISINOPRIL 275 240 1 4
SIMVASTATIN 258 226 2 2
LEVOTHYROXINE SODIUM 254 219 3 6
AMLODIPINE BESYLATE 244 214 4 3
OMEPRAZOLE 235 183 5 5
ATORVASTATIN CALCIUM 207 190 6 13
LOSARTAN POTASSIUM 157 140 7 26
ALENDRONATE SODIUM 151 150 8 42
METOPROLOL SUCCINATE 148 122 9 9
FUROSEMIDE 129 110 10 7
METFORMIN HCL 126 118 11 14
TRAMADOL HCL 122 85 12 15
ATENOLOL 118 92 13 47
SERTRALINE HCL 108 91 14 38
OXYBUTYNIN CHLORIDE ER 102 88 15 178
TRAZODONE HCL 100 79 16 43
HYDROCODONE-ACETAMINOPHEN 96 54 S3 17 1
HYDROCHLOROTHIAZIDE 94 88 18 29
FLUTICASONE PROPIONATE 93 74 19 50
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 71 20 39
METHYLPREDNISOLONE 84 70 21 169
ZETIA 83 78 22 100
GABAPENTIN 79 52 23 8
CLOPIDOGREL 77 75 24 16
PRAVASTATIN SODIUM 72 65 25 23
AMLODIPINE BESYLATE-BENAZEPRIL 68 52 26 81
GLIMEPIRIDE 67 58 27 51
CYCLOBENZAPRINE HCL 67 41 R 27 63
TRIAMTERENE-HCTZ 66 46 29 138
CRESTOR 62 50 30 20
MELOXICAM 61 56 31 27
CARVEDILOL 60 59 32 12
WARFARIN SODIUM 58 56 33 18
AMOX TR-POTASSIUM CLAVULANATE 56 42 34 238
METFORMIN HCL ER 56 54 34 94
ENALAPRIL MALEATE 56 48 34 62
TAMSULOSIN HCL 55 48 37 21
DIOVAN 54 54 38 35
JANUVIA 53 51 39 70
PLAVIX 53 50 39 25
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 48 41 91
NIASPAN 51 51 42 211
DIGOXIN 51 51 42 33
ALLOPURINOL 50 48 44 61
FENOFIBRATE 50 42 44 152
MIRTAZAPINE 50 43 44 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 27, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.